Miami Neuroscience Symposium, Tenth Annual

Miami, FL US
November 3, 2022 to November 5, 2022
image

Live Symposium | 17.75 Cat. 1
November 3-5, 2022 | Thursday-Saturday
Hilton Miami Dadeland, Miami, Florida

Become an Exhibitor  

This symposium offers a broad curriculum focusing on state-of-the-art, evidence-based practices for clinicians and healthcare professionals who treat and care for neuroscience patients from the emergency department through rehabilitation. The expert faculty will engage participants through complex cases, novel treatment strategies and lively panel discussions. The goal of the program is to share the most innovative and evidence-based clinical practices that have been implemented and are available to optimize patient outcomes throughout all areas of neuroscience.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

Day 1 - Thursday, November 3

  • Review updated guidelines in the management of acute stroke.
  • Describe the implications for thrombolytic therapy in acute stroke management.
  • Recognize the importance of critical care management of the neurologically ill patient.
  • Evaluate and manage patients with spine-related pathology.
  • Describe the impact of the COVID-19 virus on stroke and stroke management.

Day 2 - Friday, November 4

  • Examine recent advances in stroke rehabilitation.
  • Recognize new data regarding the effects of hypothermia after cardiac arrest.
  • Review key aspects of brain death determination.
  • Describe current diagnostic and treatment approaches to normal pressure hydrocephalus.
  • Review key concepts in secondary prevention of stroke.
  • Optimize patient selection for intravenous thrombolysis and endovascular treatment.
  • Diagnose and manage common complications encountered in the neuro ICU.
  • Apply appropriate thrombosis prevention and management in COVID-19.

Day 3 - Saturday, November 5

  • Identify patients who would benefit from high intensity focused ultrasound.
  • Explain the treatment benefits and risks associated with high intensity focused ultrasound.
  • Identify patients who would benefit from deep brain stimulation.
  • Explain the treatment benefits and risks associated with deep brain stimulation.
  • Describe the medical management and surgical treatment options for epilepsy.
  • Differentiate epilepsy treatment options available for children and adults.
  • Review the current guidelines for spine surgery.
  • Recognize the benefits of using outpatient services for spine treatment and describe how tracking patient outcomes can provide patient centric care.

Who Should Attend

Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Respiratory Therapists, Physical Therapists, Dietitians, Clinical Pharmacists, Rehabilitation and Pain Management Specialists, Occupational Therapists as well as other specialists interested in the field of neuroscience.

Registration and Fees

 Entire CourseThursdayFridaySaturday
Physicians*$355*$120 $120 $120
Baptist Health Employees$165$55 $55 $55
Other***$195$65 $65 $65
Students $80$28$28$28
Fellows**$80$28$28$28

*International physicians and physician groups of 3 or more are eligible for a 20% discount. 
**Registration must be accompanied by a letter from the Fellowship/Residency Director.
*** Non-physician groups of 3 or more are eligible for a 10% discount

Event date: Thursday, November 3, 2022 - Saturday, November 5, 2022

Course Summary
Available credit: 
  • 17.75 General certificate of attendance
  • 17.50 Nurse Practitioners
  • 17.50 Florida Board of Nursing
  • 17.50 Florida Board of Occupational Therapy
  • 17.75 Florida Board of Pharmacy
  • 21.00 Florida Board of Physical Therapy Practice
  • 17.50 Florida Board of Respiratory Therapy
Course opens: 
07/01/2022
Course expires: 
12/31/2022
Event starts: 
11/03/2022 - 8:00am EDT
Event ends: 
11/05/2022 - 1:00pm EDT
Cost:
$1.00
Rating: 
0

Agenda

Thursday, November 3
Miami Neuroscience Nursing

7:30 a.m.Continental Breakfast and Visit Exhibits 
7:55 a.m.Welcome and Recognitions 
Michael McDermott, M.D.
8:10 a.m.Introductions 
Jamelah Morton, APRN
8:13 a.m.Plenary Session: Endovascular Treatment of Cerebral Aneurysms
Guilherme Dabus, M.D. and Italo Linfante, M.D.
8:43 a.m.Panel Discussion with Questions & Answers 
Moderator: Jamelah Morton, APRN
8:58 a.m.Introductions 
Jamelah Morton, APRN
9:01 a.m.Nursing Guidelines Update: Pre-hospital/ED
Nina Cruz, APRN
9:16 a.m.Nursing Guidelines Update: Endovascular/ICU
Jessilyn Pozo, R.N.
9:31 a.m.Nursing Guidelines Update: Post-acute/Discharge
Nina Cruz, APRN
9:46 a.m.Panel Discussion with Questions & Answers 
Moderator: Jamelah Morton, APRN
10:01 a.m.Break and Visit Exhibits 
10:31 a.m.Introductions 
Jessilyn Pozo, R.N.
10:34 a.m.CT Perfusion Overestimation- Ghost Infarct Core
Kevin Abrams, M.D.
10:49 a.m.Off-Label Alteplase
Felipe De Los Rios La Rosa, M.D.
11:04 a.m.Tenecteplase vs. Alteplase
Tom Wolfel, Pharm.D.
11:19 a.m.Panel Discussion with Questions & Answers 
Moderator: Jessilyn Pozo, R.N.
11:34 a.m.Introductions 
Jessilyn Pozo, R.N.
11:37 a.m.Anticoagulation: Current Status
Jonathan Kline, Pharm.D.
11:52 a.m.Anticonvulsant Management in the Patient in Status Epilepticus 
Jessica Greenwood, Pharm.D.
12:07 p.m.Lunch and Visit Exhibits 
1:07 p.m.Introductions 
Alex Perez, MSN, APRN
1:10 p.m.Spine Certification
Sanya Arscott, R.N.
1:25 p.m.Hi-Fu Case Presentation
Justin Sporrer, M.D.
1:40 p.m.Pearls to the Lumbar Radiculopathy Exam
Ronald Tolchin, D.O.
1:55 p.m.Enhanced Recovery After Surgery  
Sanya Arscott, R.N.
2:10 p.m.Panel Discussion with Questions & Answers 
Moderator: Alex Perez, MSN, APRN
2:25 p.m.Break and Visit Exhibits 
2:55 p.m.Introductions 
Aimee Green, MSN, APRN
2:58 p.m.Non-surgical Management of Intracranial Hypertension 
Kendra Kent, MSN
3:13 p.m.Neurosurgical Management of Intracranial Hypertension
Robert Wicks, M.D.
3:28 p.m.Cardiovascular Complications in the Patient with Subarachnoid Hemorrhage
Kendra Kent, MSN
3:43 p.m.Sodium Management Stable in Critically Ill Neurologic Patients
Jamelah Morton, APRN
3:58 p.m.Panel Discussion with Questions & Answers 
Moderator: Aimee Green, MSN, APRN
4:13 p.m.Introductions 
Alex Perez, MSN, APRN
4:16 p.m.Evidence Based Physical Therapy Approaches to Lumbar and Cervical Spine Conditions
Cristina Parsons, PT, MS
4:31 p.m.Dorsal Root Ganglion Stimulation in the Treatment of Intractable Neuropathic Pain
Moises Lustgarten, M.D.
4:46 p.m.Surgical Management of Herniated Disks 
Jason Liounakos, M.D.
5:01 p.m.Panel Discussion with Questions & Answers 
Moderator: Alex Perez, BSN, R.N.
5:16 p.m.Adjourn

Friday, November 4
Stroke, Cerebrovascular, Neurocritical Care, Neurosurgery

7:30 a.m.Continental Breakfast and Visit Exhibits 
7:55 a.m.Welcome and Introductions
Felipe De Los Rios La Rosa, M.D.
8:00 a.m.Plenary Session: What You Need to Know: The 2021 AHA/ASA Updates for Secondary Prevention of Stroke 
Dawn Kleindorfer, M.D.
8:30 a.m.Basilar Artery Occlusion – A treatable Stroke in Disguise
Ivan Matos, M.D.
8:45 a.m.Update on Cerebral Venous Sinus Thrombosis
Nerissa Ko, M.D.
9:00 a.m.Panel Discussion with Questions & Answers 
Moderator: Felipe De Los Rios La Rosa, M.D.
9:15 a.m.Break and Visit Exhibits 
9:45 a.m.Introductions 
Italo Linfante, M.D.
9:48 a.m.The Present and Future of Telestroke & Teleneurology
Neeraj Singh, M.D.
10:03 a.m.Ghost Infarct Core and Perfusion Scotoma 
Kevin Abrams, M.D.
10:18 a.m.Covid-19 and Thrombosis: Who Should We Anticoagulate?  
Srikanth Nagalla, M.D.
10:33 a.m.Panel Discussion with Questions & Answers 
Moderator: Italo Linfante, M.D.
10:48 a.m.Introductions 
Robert Wicks, M.D.
10:51 a.m.Advances in Stroke Rehabilitation 
Luis A. Orengo, M.D.
11:06 a.m.Combination Antithrombotic in Cardiovascular Disease 
Ian Del Conde, M.D.
11:21 a.m.Should we Recommend Anticoagulation Therapy in the Elderly and Frail? 
Tarak Rambhatla, M.D
11:36 a.m.Patent Foramen Ovale: To Close or Not to Close? 
Dawn Kleindorfer, M.D.
11:51 a.m.Panel Discussion with Questions & Answers 
Moderator: Robert Wicks, M.D.
12:06 p.m.Lunch and Visit Exhibits
1:06 p.m.Introductions 
Vitaly Siomin, M.D.
1:09 p.m.Thromboembolism Prevention in Cerebrovascular Diseases 
Marisa Gilbert, M.D.
1:24 p.m.New Frontiers in Endovascular Treatment of Acute Stroke
Italo Linfante, M.D
1:39 p.m.Advancements in the Endovascular Management of Subdural Hematomas
Robert Wicks, M.D.
1:54 p.m.Carotid and Vertebral Revascularization: Current Endovascular Management
Guilherme Dabus, M.D.
2:09 p.m.Panel Discussion with Questions & Answers
Moderator: Vitaly Siomin, M.D.
2:24 p.m.Break and Visit Exhibits 
2:54 p.m.Introductions
Karel Fuentes, M.D.
2:59 p.m.Preventing and Treating Delayed Cerebral Injury in SAH
Javier Provencio, M.D.
3:14 p.m.Osmotherapy in the Neuro ICU 
Karel Fuentes, M.D.
3:29 p.m.Is Normothermia After Cardiac Arrest the New Cool?
Javier Provencio, M.D.
3:44 p.m.Key Considerations in Brain Death Determination
Mohammad Abou-El-Fadl, M.D.
3:59 p.m.Surgical Treatment of Cerebral Aneurysms
Vitaly Siomin, M.D.
4:14 p.m.Laser Interstitial Therapy for Medial Temporal Lobe Epilepsy
Vitaly Siomin, M.D.
4:29 p.m.Post Subarachnoid Hemorrhage Hydrocephalus
Robert Wicks, M.D.
4:44 p.m.Panel Discussion with Questions & Answers
Moderator: Karel Fuentes, M.D.
4:59 p.m.Adjourn

Saturday, November 5
Functional Neuroscience - Spine and Rehab

7:30 a.m.Continental Breakfast and Visit Exhibits 
7:55 a.m.Welcome
Ronald Tolchin, M.D.
8:00 a.m.Introductions
Diego Torres-Russotto, M.D.
8:03 a.m.Patient Selection for High Intensity Focused Ultrasound
Justin Sporrer, M.D.
8:18 a.m.Update on Deep Brain Stimulation for Tremor
Kelly Foote, M.D.
8:33 a.m.Emerging Surgical Based Therapies for Parkinson's Disease
Aviva Abosch, M.D.
8:48 a.m.Results of DBS for Rigidity and Bradykinesia
Diego Torres-Russotto, M.D.
9:03 a.m.Panel Discussion with Questions & Answers 
Moderator: Diego Torres-Russotto, M.D.
9:18 a.m.Break and Visit Exhibits 
9:48 a.m.Introductions
Alberto Pinzon-Ardila, M.D., Ph.D.
9:51 a.m.Anti-epileptic Drug Utilization in Non-epilepsy Neuro Critical Care Patients 
Alberto Pinzon-Ardila, M.D., PhD.
10:06 a.m.Indications for Surgery and Adult Epilepsy 
Iahn Cajigas, M.D., PhD
10:21 a.m.Indications for Surgery and Childhood Epilepsy 
John Ragheb, M.D.
10:36 a.m.Normal Pressure Hydrocephalus 
Michael McDermott, M.D.
10:51 a.m.Panel Discussion with Questions & Answers 
Moderator: Alberto Pinzon-Ardila, M.D., Ph.D.
11:06 a.m.Introductions
Mark Hadley, M.D.
11:09 a.m.Role of Intraoperative Monitoring and Spine Surgery: Guidelines
Mark Hadley, M.D.
11:24 a.m.Spinal Radiosurgery 
Robert J. Rothrock, M.D.
11:39 a.m.Spine Surgery 
Michael Gomez, M.D.
11:54 a.m.Panel Discussion with Questions & Answers 
Moderator: Mark Hadley, M.D.
12:09 p.m.Introductions
Mark Hadley, M.D.
12:12 p.m.Outpatient Spine Surgery: Rationale and Trends 
Jason Liounakos, M.D.
12:27 p.m.Risk Profiles Stratification for Outpatient Cervical Spine Surgery
Jason Liounakos, M.D.
12:42 p.m.Complex Spine Surgery: Tracking Outcomes 
Raul Vasquez, M.D.
12:57 p.m.Panel Discussion with Questions & Answers 
Moderator: Mark Hadley, M.D.
1:12 p.m.Adjourn

Return to Top  

NOTE: Schedule subject to change.

Hilton Miami Dadeland
9100 N Kendall Dr
Miami, FL 33176
United States
+1 (786) 975-1920

About the Venue

Next to Baptist Hospital, Hilton Miami is two miles from Dadeland Mall and 10 minutes from Dadeland South Metro Station. Miami International Airport is 13 miles away. Hilton Miami offers a wellness center with yoga and Pilates classes plus massages, a heated pool, and guest rooms with fitness equipment. Hilton Miami Dadeland has met cleanliness standards for a WELL Health-Safety Rating.

Symposium Directors and Planners

image
Kevin Abrams, M.D.
Chief, Radiology
Medical Director, Neuroradiology and Magnetic Resonance Imaging
Baptist Hospital of Miami
Clinical Associate Professor of Radiology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Guilherme Dabus, M.D.
Co-director, Interventional Neuroradiology
Miami Neuroscience Institute
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery
Miami Cardiac & Vascular Institute and Miami Neuroscience Institute
Clinical Professor, Department of Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Michael W. McDermott, M.D., FAANS
Chief Physician Executive, Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami, Florida
image
Felipe De Los Rios La Rosa, M.D., FAHA
Medical Director, Stroke Program
Miami Neuroscience Institute
Miami, Florida
image
Karel Fuentes, M.D.
Neurointensivist and Medical Director, Neurocritical Care
Miami Neuroscience Institute
Clinical Assistant Professor of Neurology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Italo Linfante, M.D., FAHA
Director, Interventional Neuroradiology
Miami Neuroscience Institute
Clinical Professor of Radiology and Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Alberto Pinzon-Ardila, M.D., Ph.D.
Neurologist and Medical Director, Epilepsy Program
Miami Neuroscience Institute
Miami, Florida
image
Vitaly Siomin, M.D.
Neurosurgeon and Medical Director, Brain Tumor Program
Director, Cerebrovascular Neurosurgery
Co-Director, Skull Base Surgery
Miami Neuroscience Institute
Miami, Florida
image
Justin M. Sporrer, M.D.
Neurosurgeon and Director, Functional Neurosurgery
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Ronald B. Tolchin, D.O.
Physical Medicine & Rehabilitation
Medical Director, Spine Center
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida

Nursing Planners

image
Starlie Belnap, Ph.D.
Clinical Research Supervisor
Miami Neuroscience Institute
image
Jamelah Morton, Ph.D., APRN, ACNP-BC, CCRN, CNRN, SCRN
Neurosurgery Advance Practice Provider Supervisor
Miami Neuroscience Institute
Miami, Florida
image
Jessilyn Pozo, DNP, APRN, AGACNP-BC, SCRN
Baptist Health System-wide Stroke Program Manager
Miami Neuroscience Institute
Miami, Florida

Presenters

image
Aviva Abosch, M.D., Ph.D.
Professor, Nancy A. Keegan and Donald R. Voelte, Jr. Chair and the Inaugural Chair, Department of Neurosurgery
University of Nebraska Medical Center
Co-Director, Neurosciences Services
Omaha, Nebraska
image
Mohammed Abou-El-Fadl, M.D.
Critical Care and Neurocritical Care Medicine
Baptist Hospital of Miami
Baptist Health Quality Network
Miami, Florida
image
Kevin Abrams, M.D.
Chief, Radiology
Medical Director, Neuroradiology and Magnetic Resonance Imaging
Baptist Hospital of Miami
Clinical Associate Professor of Radiology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Sanya K. Arscott, BSN, R.N.
Supervisor, Spine Program
Marcus Neuroscience Institute
Boca Raton Regional Hospital
Boca Raton, Florida 
image
Iahn Cajigas, M.D., Ph.D.
Epilepsy, Functional and Stereotactic Neurosurgery Fellow
Department of Neurological Surgery
University of California, San Francisco
San Francisco, California
image
Nina Cruz, MSN, APRN, FNP-BC, SCRN
Coordinator, Stroke Program
Baptist Hospital of Miami
Neuroscience Research
Miami Neuroscience Institute
Miami, Florida 
image
Guilherme Dabus, M.D.
Co-director, Interventional Neuroradiology
Miami Neuroscience Institute
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery
Miami Cardiac & Vascular Institute and Miami Neuroscience Institute
Clinical Professor, Department of Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Ian Del Conde Pozzi, M.D., FACC
Director, Vascular Medicine
Associate Director, Cardiology
Miami Cardiac & Vascular Institute
Miami, Florida
image
Felipe De Los Rios La Rosa, M.D., FAHA
Medical Director, Stroke Program
Miami Neuroscience Institute
Miami, Florida 
image
Kelly D. Foote, M.D.
Professor, Lillian S. Wells Department of Neurosurgery
University of Florida College of Medicine
Co-Director, Norman Fixel Institute for Neurological Diseases
University of South Florida Health
Professor, Donnellan/Einstein/Merz, Functional Neurosurgery
Gainesville, Florida
image
Karel Fuentes, M.D.
Neurointensivist and Medical Director, Neurocritical Care
Miami Neuroscience Institute
Clinical Assistant Professor of Neurology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Michael E. Gomez, M.D., FAANS
Director, Minimally Invasive Spine Surgery
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida 
image
Aimee Green, MSN, APRN, AGACNP-BC, CCRN
Nurse Practitioner, Intensive Care
Baptist Health South Florida
Miami, Florida
image
Jessica Greenwood, Pharm.D. BCPP
Neurology Clinical Pharmacy Specialist
Baptist Hospital of Miami
Miami, Florida
image
Mark Hadley, M.D.
Neurosurgery and Spine Surgery
Charles A. and Patsy W. Collat Endowed Chair in Neurosurgery
Director Emeritus, Neurosurgery Residency Program
Professor, University of Alabama
Birmingham, Alabama
image
Kendra Kent, R.N., MS, CCRN, CNRN, SCRN, TCRN, CENP
Director of Neuroscience Programs
Marcus Neuroscience Institute
Boca Raton Regional Hospital
Boca Raton, Florida
image
Laiqua Khalid, M.D.
Pulmonary and Critical Care Medicine
Baptist Health South Florida
Miami, Florida
image
Dawn O. Kleindorfer, M.D.
Chair, Department of Neurology
Professor, University of Michigan Medical School
Ann Arbor, Michigan
image
Jonathan Kline, Pharm.D., BCCCP
Neurocritical Care Clinical Pharmacy Specialist
Baptist Hospital of Miami
Miami, Florida
image
Nerissa U. Ko, M.D., MAS
Professor and Vice Chair for Diversity, Department of Neurology
William K. Bowes Foundation Endowed Chair of Neurocritical Care
Medical Director, Adult Neurointensive Care Units
Director, Neurocritical Care Fellowship Program
UCSF Weill Institute for Neurosciences
University of California, San Francisco
San Francisco, California
image
Italo Linfante, M.D., FAHA
Director, Interventional Neuroradiology
Miami Neuroscience Institute
Clinical Professor of Radiology and Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
image
Jason Liounakos, M.D.
Chief Resident, Department of Neurological Surgery
University of Miami-Jackson Memorial Hospital
Miami, Florida
image
Javier Lopez, M.D.
Neurologist
Baptist Health Quality Network
Miami, Florida 
image
Moses Lustgarten, M.D.
Medical Director, Pain Management
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Ivan Matos, M.D.
Vascular Neurologist
Associate Medical Director, Stroke Program  
Miami Neuroscience Institute
Miami, Florida 
image
Michael W. McDermott, M.D., FAANS
Chief Physician Executive, Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami, Florida
image
Jamelah Morton, Ph.D., APRN, ACNP-BC, CCRN, CNRN, SCRN
Neurosurgery Advance Practice Provider Supervisor
Miami Neuroscience Institute
Miami, Florida
image
Srikanth Nagalla, M.D., M.S.
Chief, Benign Hematology
Miami Cancer Institute
Miami, Florida
image
Luis A. Orengo, M.D.
Medical Director, Baptist Health Rehabilitation
Baptist Health Quality Network
Miami, Florida
image
Cristina Parsons, P.T.
Outpatient Rehabilitation Services
Baptist Hospital of Miami
Miami, Florida
image
Alex Perez, BSN, R.N.
Spine Coordinator
South Miami Hospital
South Miami, Florida
image
Alberto Pinzon-Ardila, M.D., Ph.D.
Neurologist and Medical Director, Epilepsy Program
Miami Neuroscience Institute
Miami, Florida 
image
Jessilyn Pozo, DNP, APRN, AGACNP-BC, SCRN
Baptist Health System-wide Stroke Program Manager
Miami Neuroscience Institute
Miami, Florida
image
Jose Javier Provencio, M.D., FCCM, FAAN, FNCS
Louise Nerancy Professor in Neurology
Director, Nerancy Neuroscience Intensive Care Unit and Neurointermediate Care Unit
Division Head, Hospital Medicine, Department of Neurology
University of Virginia Health System
Translational Researcher, Center for Brain Immunology and Glia
Charlottesville, Virginia
image
John Ragheb, M.D.
Chief, Department of Surgery
Director, Division of Neurosurgery
Nicklaus Children’s Hospital
Miami, Florida
image
Tarak Rambhatla, M.D., FACC
Medical Director, Inpatient Cardiac Services
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Robert J. Rothrock, M.D.
Spinal Neurosurgeon
Director, Spinal Oncology
Miami Neuroscience Institute
Baptist Health Quality Network
Assistant Professor, Neurosurgery
Herbert Wertheim College of Medicine, Florida International University
Miami, Florida
image
Neeraj Singh, M.D.
Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Chief Resident, Albany Medical Center Hospital
Neurology Specialist, Northwell Health Physician Partners Neuroscience Institute at Great Neck
Great Neck, New York
image
Vitaly Siomin, M.D.
Neurosurgeon and Medical Director, Brain Tumor Program
Director, Cerebrovascular Neurosurgery
Co-Director, Skull Base Surgery
Miami Neuroscience Institute
Miami, Florida
image
Justin M. Sporrer, M.D.
Neurosurgeon and Director, Functional Neurosurgery
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Ronald Tolchin, D.O.
Physical Medicine & Rehabilitation
Medical Director, Spine Center
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Diego Torres-Russotto, M.D.
Professor and Vice-Chair, Neurological Sciences
Chief, Movement Disorders Division
Program Director, Movement Disorders Fellowship
University of Nebraska Medical Center
Omaha, Nebraska
image
Alexandra Turcios, MSN, APRN, RNFA, ACNP-BC
Advanced Practice Provider Manager
Miami Neuroscience Institute
Miami, Florida
image
Raul Vasquez-Castellanos, M.D.
Director, Complex Spine Neurosurgery
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Miami, Florida
image
Robert Wicks, M.D.
Co-director, Cerebrovascular Surgery
Director, Neurosurgery Anatomy Laboratory
Miami Neuroscience Institute
Miami, Florida
image
Thomas J. Wolfel, Pharm.D. BCCCP
Emergency Medicine Clinical Pharmacy Specialist
Baptist Hospital of Miami
Miami, Florida

Disclosures And Resolution Of Conflict Of Interest

Disclosure Policy and Disclaimer

Accreditation

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a total of 17.75 credit hours, CE Broker Course # 20-932286 (Thursday – 6.75), CE Broker Course # 20-932332 (Friday – 6.5), and CE Broker Course # 20-932344 (Saturday- 4.5), by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has been approved for a total of 17.75 credit hours, CE Broker Course # 20-932286 (Thursday – 6.75), CE Broker Course # 20-932332 (Friday – 6.5), and CE Broker Course # 20-932344 (Saturday- 4.5) for Pharmacists and Techs. Baptist Health South Florida CE Broker Provider #50-182.

This activity has also been approved for 17.5 credits, CE Broker Course # 20-932286 (Thursday – 6.5), CE Broker Course # 20-932332 (Friday – 6.5), and CE Broker Course # 20-932344 (Saturday- 4.5) for Nurse Practitioners, Nurses, and Respiratory Therapists (direct delivery) and Occupational Therapists. Baptist Health South Florida CE Broker Provider #50-182.

Physical Therapy credits have been approved by the Florida Board of Physical Therapy. 

ASET-The Neurodiagnostic Society -  18 ASET-CEUs are awarded for completion of this course. 

 This educational activity has been endorsed by the Congress of Neurological Surgeons as relevant to the practice of Neurological Surgery and meets the criteria for Category 1 Neurosurgical Credits as defined by the American Board of Neurological Surgery.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Disclaimer

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Available Credit

  • 17.75 General certificate of attendance
  • 17.50 Nurse Practitioners
  • 17.50 Florida Board of Nursing
  • 17.50 Florida Board of Occupational Therapy
  • 17.75 Florida Board of Pharmacy
  • 21.00 Florida Board of Physical Therapy Practice
  • 17.50 Florida Board of Respiratory Therapy

About the Exhibitors

Acorda Therapeutics

Acorda Therapeutics, Inc. is an American biotechnology company based in New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders.

Aesculap

Founded over 150 years ago, Aesculap is the world’s leading manufacturer of surgical instrumentation and sterilization containers.   Coupling old-world craftsmanship with cutting edge innovation, the company remains on the vanguard of medical technology, producing advanced products for disciplines such as neuro, spine and joint replacement surgeries with a strong emphasis in the areas of hydrocephalus management, high speed and micro power systems, and robotic microscopy. 

Alexion Pharmaceuticals

Alexion, AstraZeneca Rare Disease, was created in 2021 following AstraZeneca’s acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals began in 2013 with a simple question “Why do neurons die?”  Our mission is centered on a commitment to people living with neurodegenerative diseases, their families and to the healthcare providers who support them. This start-up is headquartered in Cambridge, MA with offices in Canada and Europe.

AstraZeneca Pharmaceuticals

AstraZeneca is a global science-led biopharmaceutical company.

Azurity Pharmaceuticals

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company. The portfolio of products marketed in the U.S. by Azurity includes GLIADEL® Wafer (carmustine implant) and Nymalize® (nimodipine) Oral Solution, the first and only FDA-approved nimodipine oral solution. Gliadel® is manufactured by Eisai Inc. for Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc. and Gliadel® is a registered trademark of Eisai Inc.

BK Medical

BK Medical provides reassurance for decision-making in neurosurgery. Whether you specialize in neuro-oncology, skull base, spine, neurovascular, functional, or pediatrics, use real-time intraoperative ultrasound to achieve planned results.

BrainLab

Brainlab creates software-driven med tech digitizing, automating and optimizing clinical workflows. Serving physicians, medical professionals and patients in 6000+ hospitals in 121 countries, we’re transforming healthcare to improve the lives of patients everywhere. We employ over 2000 people in 25 locations worldwide. Visit and follow: BrainlabLinkedIn Twitter Facebook  and Instagram .

Ceribell

Ceribell is a medical device company with a primary mission of improving neurological care for emergency and ICU patients. We’ve developed the world’s first point-of-care noninvasive brain function monitor for critical and emergency care. This device integrates machine learning AI and cloud-based computing with miniaturized EEG technology so it is easy to apply and use. Now, with Ceribell, rapid EEG technology can be brought to frontline emergency and critical care doctors so you have rapid clinical answers at the bedside.

CSL Behring

CSL Behring is a global bio therapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders.

DePuy Synthes Spine

DePuy Synthes, the Orthopedics Company of Johnson & Johnson, provides one of the most comprehensive Orthopedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. DePuy Synthes Spine offers an expansive portfolio of spinal care solutions and treatment options which are available in key areas including thoracolumbar, cervical, aging spine, interbody fusion, and arthroplasty.  Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. 

Elekta

Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders

Hyperfine

Hyperfine is the groundbreaking medical device company that created Swoop®, the world’s first US FDA-cleared portable MRI system—created to provide neuroimages at the patient’s bedside and enable rapid diagnosis and treatment regardless of income, resources, or location. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making insights across various clinical settings.

Jazz Pharmaceuticals

At Jazz Pharmaceuticals plc, our purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases – often with limited or no options – so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.

LivaNova

As pioneers of the VNS Therapy System ™, we continue to advance medical device solutions for people affected by treatment-resistant epilepsy. We strive to help where it really counts, where it truly matters the most. Sharp, responsive and effective—at LivaNova we serve health and improve lives. Day by day. Life by life.

Lundbeck Pharmaceuticals

Lundbeck, a global biopharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so that every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health. For more information, visit us at www.lundbeck.com/us.

Marinus Pharmaceuticals

Marinus is a commercial stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s lead product candidate, ganaxolone oral suspension CV, is approved by the FDA for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder in patients two years of age and older. The potential of ganaxolone is being studied in other rare seizure disorders, including in Phase 3 trials in tuberous sclerosis complex and refractory status epilepticus. Ganaxolone is a neuroactive steroid GABAA receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings. For more information visit www.marinuspharma.com.

MedSol

MedSol has maintained its mission of providing clinically superior products that demonstrate proven advantages in quality, efficiency, safety and overall cost.

Medtronic Brain and Spine

Our mission is to contribute to human welfare by application of biomedical engineering and medical devices in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.

Miami Neuroscience Institute

Miami Neuroscience Institute offers comprehensive and compassionate treatment for neurological conditions affecting the brain, spinal cord and peripheral nervous system. From non-surgical treatments and minimally invasive procedures to complex brain and spine surgery, the Institute embraces a multidisciplinary approach to patient care.

Microvention

MicroVention provides a complete 360-degree approach to developing neuroendovascular technologies with four main product groups: Aneurysm Therapy Solutions, Ischemic Stroke and Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products. Additionally, our extensive product lines in each category allow our customers to uniquely address the needs of their patients.

Neurelis

Neurelis, Inc. is an innovation-driven neuroscience company providing a highly differentiated approach to target unmet medical needs.  Neurelis is focused on the development and commercialization of product candidates for epilepsy and the broader central nervous system (CNS) market.  We are built on a foundation of people with a passion for progress in serving the needs of people with epilepsy and those who care for them.

Neurocrine Biosciences

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and commercializing life-changing treatments for people with serious, challenging and under-addressed disorders. The company's diverse portfolio includes four FDA-approved treatments as well as clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms. For more information, visit neurocrine.com, and follow the company on LinkedIn.

NicoNeuro

NICO is a leader in interventional technologies for neurosurgery. Using a parafascicular trans-sulcal surgical approach, a combination of standardized patented technologies achieves non-disruptive access to the brain with NICO BrainPath, automated tumor removal and clot evacuation with NICO Myriad NOVUS, and intraoperative tissue collection and preservation with the NICO Automated Preservation System. A proven market leader with over 10 years of evidence and 30,000 patient lives impacted.

Octapharma

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell lines. Octapharma employs more than 10,000 people worldwide to support the treatment of patients in over 115 countries with products across the following therapeutic areas: Hematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care. The company’s American subsidiary, Octapharma USA, is located in Paramus, N.J. Octapharma operates three state-of-the-art production sites licensed by the U.S. Food and Drug Administration (FDA), providing a high level of production flexibility. For more information, please visit octapharmausa.com.

Omniscient Neurotechnology

Omniscient Neurotechnology (o8t™) builds personalized brain maps to diagnose, treat and prevent health conditions. A pioneer in connectomics, o8t™ is poised to change the future of neuroscience. Currently used by neurosurgeons to visualize the brain’s pathways prior to a procedure, the company’s technology ultimately aims to transform brain health and address conditions such as Alzheimer’s disease and depression.

Penumbra

“Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries.”

Rapid AI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Empowering physicians to make faster decisions for better patient outcomes. RapidAI is leading the next evolution of clinical decision-making and patient workflow. Based on intelligence gained from over 5 million scans in more than 2,000 hospitals in over 60 countries, the Rapid®️ platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.

Siemens Healthineers

By constantly bringing breakthrough innovations to market, Siemens Healthineers enables healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. At Siemens Healthineers, our mission is to enable healthcare providers to increase their value by equipping them with our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. Our global portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the biggest challenges in healthcare. We will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.

SMI Cold Therapy

SMI Cold Therapy is a Virginia based manufacturer of simple, but effective cold compression therapy wraps for post-op ortho/neuro, general surgery, and oncology used by over 600 programs nationwide. Proud to be 100% Made in America, SMI is clinically proven to provide the highest levels of pain/edema relief, while eliminating several patient and staff hassles.

Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Sunovion Pharmaceuticals

At Sunovion, we strive to serve and create value for patients every day. By developing innovative therapies that treat serious Central Nervous System (CNS) conditions, science leads the way—guiding us to a healthier tomorrow.

TEVA Neuroscience

In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.

UCB

UCB is focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions.

Viz.Ai

Viz.ai is the leader in AI-driven intelligent care coordination. Viz.ai’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation.

Price

Cost:
$1.00
Please login or register for a Baptist Health CME account to take this course.

COVID-19 Protocols Notice for All Attendees, Exhibitors and Vendors

Self-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person.

CDC Self-Screening Tool

Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity.

Learn More